Patricia J M Best

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
    Patricia J M Best
    Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
    Catheter Cardiovasc Interv 77:232-41. 2011
  2. ncbi request reprint Prevention and management of contrast-induced acute kidney injury
    Patricia J M Best
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    Curr Treat Options Cardiovasc Med 14:1-7. 2012
  3. doi request reprint The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
    Patricia J M Best
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 155:687-93. 2008
  4. doi request reprint SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
    Patricia J M Best
    Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    EuroIntervention 6:866-74. 2011
  5. doi request reprint SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
    Patricia J M Best
    Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
    Heart Lung Circ 20:83-90. 2011
  6. ncbi request reprint Cardiovascular disease and chronic kidney disease: insights and an update
    Patricia J M Best
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 148:230-42. 2004
  7. doi request reprint High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice
    Joerg Herrmann
    Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA
    Circ Cardiovasc Interv 5:783-90. 2012
  8. ncbi request reprint Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
    Am Heart J 146:345-50. 2003
  9. doi request reprint Clinical features, management, and prognosis of spontaneous coronary artery dissection
    Marysia S Tweet
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 126:579-88. 2012
  10. ncbi request reprint Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial
    Patricia J M Best
    Mayo Clinic, Rochester, Minnesota, USA
    J Am Coll Cardiol 44:1786-91. 2004

Detail Information

Publications28

  1. doi request reprint SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
    Patricia J M Best
    Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
    Catheter Cardiovasc Interv 77:232-41. 2011
    ..However, radiation exposure among pregnant physicians should be properly monitored and adequate radiation safety measures are still warranted...
  2. ncbi request reprint Prevention and management of contrast-induced acute kidney injury
    Patricia J M Best
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    Curr Treat Options Cardiovasc Med 14:1-7. 2012
    ..Normal saline has been the standard, but other options such as sodium bicarbonate may be a reasonable alternative. Further studies will be required to clarify the best preventive strategies...
  3. doi request reprint The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
    Patricia J M Best
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 155:687-93. 2008
    ..Therapy with clopidogrel decreases adverse events in large patient populations. Therefore, we sought to determine the efficacy and safety of long-term clopidogrel therapy in patients with CKD...
  4. doi request reprint SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
    Patricia J M Best
    Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    EuroIntervention 6:866-74. 2011
    ..However, radiation exposure among pregnant physicians should be properly monitored and adequate radiation safety measures are still warranted...
  5. doi request reprint SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
    Patricia J M Best
    Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
    Heart Lung Circ 20:83-90. 2011
    ..However, radiation exposure amongst pregnant physicians should be properly monitored and adequate radiation safety measures are still warranted...
  6. ncbi request reprint Cardiovascular disease and chronic kidney disease: insights and an update
    Patricia J M Best
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 148:230-42. 2004
    ..This review outlines our current understanding of CKD as a cardiovascular risk factor, treatment options, and the future directions that are needed to treat cardiovascular disease in patients with CKD...
  7. doi request reprint High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice
    Joerg Herrmann
    Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA
    Circ Cardiovasc Interv 5:783-90. 2012
    ..Whether hsCRP is a useful biomarker for risk stratification in contemporary percutaneous coronary intervention remains unknown...
  8. ncbi request reprint Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
    Am Heart J 146:345-50. 2003
    ..Abciximab reduces complications, but may cause excessive bleeding in patients with CRI. Therefore, we sought to determine the safety of abciximab in patients with CRI...
  9. doi request reprint Clinical features, management, and prognosis of spontaneous coronary artery dissection
    Marysia S Tweet
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 126:579-88. 2012
    ..Spontaneous coronary artery dissection (SCAD) is an acute coronary event of uncertain origin. Clinical features and prognosis remain insufficiently characterized...
  10. ncbi request reprint Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial
    Patricia J M Best
    Mayo Clinic, Rochester, Minnesota, USA
    J Am Coll Cardiol 44:1786-91. 2004
    ..The goal of this study was to determine if restenosis is increased in mild and moderate chronic kidney disease (CKD) patients after percutaneous coronary intervention (PCI)...
  11. doi request reprint Outcomes after coronary stent implantation in patients with metal allergy
    Santiago Romero-Brufau
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 5:220-6. 2012
    ..Clinical outcomes after stent placement in patients with a history of metal allergy remain incompletely understood. We performed a single-center retrospective study to evaluate such outcomes...
  12. ncbi request reprint Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia
    Piero O Bonetti
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Atherosclerosis 168:367-73. 2003
    ....
  13. pmc A multicenter, prospective study to evaluate the use of contrast stress echocardiography in early menopausal women at risk for coronary artery disease: trial design and baseline findings
    Sahar S Abdelmoneim
    Cardiovascular Ultrasound Imaging and Hemodynamic Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    J Womens Health (Larchmt) 22:173-83. 2013
    ..This report describes the study design, population, and initial test results at study entry...
  14. ncbi request reprint The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial
    Peter B Berger
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Am Heart J 149:869-75. 2005
    ..In particular, whether outcome differences exist between agents that are renally excreted (tirofiban) or not (abciximab) in patients with mild renal impairment is not known...
  15. ncbi request reprint Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience
    Emmanouil S Brilakis
    Division of Cardiovascular Diseases, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Catheter Cardiovasc Interv 66:333-40. 2005
    ..Stent deployment or crushing may be a good alternative to retrieval...
  16. doi request reprint Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation
    Aaron M From
    Division of Cardiovascular Diseases, Department of Internal Medicine, Rochester, Minnesota, USA
    Am J Cardiol 106:1081-5. 2010
    ..The study results suggest that detection of these patients has been suboptimal, highlighting the need to improve the diagnostic approach toward the detection of an acutely occluded LC artery...
  17. doi request reprint Prevalence of migraine and Raynaud phenomenon in women with apical ballooning syndrome (Takotsubo or stress cardiomyopathy)
    Dawn C Scantlebury
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
    Am J Cardiol 111:1284-8. 2013
    ..The absence of an association with reproductive characteristics and the finding that ABS occurred despite exogenous hormonal use in some patients suggests that estrogen deficiency per se is not the primary factor in the pathophysiology...
  18. ncbi request reprint Pro: standard percutaneous coronary intervention is the procedure of choice for myocardial revascularization
    Patricia J M Best
    Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    J Cardiothorac Vasc Anesth 17:263-8. 2003
  19. ncbi request reprint Can percutaneous coronary interventions reduce death and myocardial infarction in stable and unstable coronary disease?
    Patricia J M Best
    Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 27715, USA
    Catheter Cardiovasc Interv 61:528-36. 2004
  20. ncbi request reprint Clopidogrel-associated autoimmune thrombocytopenic purpura
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Mayo Foundation, Rochester, Minnesota, USA
    Catheter Cardiovasc Interv 62:339-40. 2004
    ..One week later, he developed symptomatic autoimmune thrombocytopenia likely related to clopidogrel use. This was successfully treated with intravenous methylprednisilone and platelet transfusions...
  21. doi request reprint Cardiovascular disease in older women: a challenge in diagnosis and treatment
    Rekha Mankad
    Mayo Clinic, Division of Cardiovascular Diseases, Gonda 5, 200 First Street SW, Rochester, MN 55905, USA
    Womens Health (Lond Engl) 4:449-64. 2008
    ..This article will discuss the current guidelines for diagnosis and therapy of heart disease in women and will discuss the appropriate role of prevention strategies...
  22. ncbi request reprint The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 39:1113-9. 2002
    ..We sought to determine the effect of varying degrees of renal insufficiency on death and cardiac events during and after a percutaneous coronary intervention (PCI)...
  23. ncbi request reprint Evidence-based practice and the nurse practitioner
    Donna M Kania-Lachance
    Mayo Clinic, Rochester, MN, USA
    Nurse Pract 31:46-54. 2006
  24. ncbi request reprint Dendroaspis natriuretic peptide relaxes isolated human arteries and veins
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Cardiovasc Res 55:375-84. 2002
    ..Since other natriuretic peptides are known to cause vasorelaxation, we determined the response to DNP on human blood vessels in vitro. We also investigated the mechanism of DNP mediated vasorelaxation...
  25. doi request reprint Metastatic malignant melanoma manifesting as an intracardiac mass
    Angela Wood
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Cardiovasc Pathol 19:153-7. 2010
    ..Antemortem diagnoses of intracardiac metastases are uncommon. Metastatic melanoma shows a propensity for cardiac involvement, but cardiac involvement by melanoma is rarely identified clinically due to a paucity of cardiac symptoms...
  26. ncbi request reprint Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs
    James D Krier
    Department of Internal Medicine, Division of Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Physiol Regul Integr Comp Physiol 283:R303-8. 2002
    ....
  27. ncbi request reprint Chronic kidney disease as a cardiovascular risk factor
    Patricia J M Best
    Am Heart J 145:383-6. 2003
  28. ncbi request reprint Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention
    Kimberly A Skelding
    Division of Cardiology, Geisinger Medical Center, Danville, Pennsylvania, USA
    J Invasive Cardiol 19:229-33. 2007
    ..Background. RCIN is associated with increased mortality and morbidity following PCI and accounts for increased hospital costs and length of stay...